Related Experiment Video
Updated: Jun 27, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Traversing a wormhole to combat Parkinson's disease
Guy A Caldwell1, Kim A Caldwell
1Department of Biological Sciences, The University of Alabama, Tuscaloosa, AL 35487, USA. gcaldwel@bama.ua.edu
Disease Models & Mechanisms
|December 3, 2008
Summary
Caenorhabditis elegans research offers new insights into Parkinson's disease (PD) mechanisms. This model aids in identifying drug targets and understanding neurodegeneration for PD susceptibility and progression.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Human movement disorders, particularly Parkinson's disease (PD), pose a significant global health challenge.
- Despite genetic advances, understanding PD susceptibility, onset, and progression remains incomplete.
- Novel strategies are crucial for identifying intracellular drug targets to accelerate clinical translation.
Purpose of the Study:
- To review the utility of Caenorhabditis elegans as a model organism for Parkinson's disease research.
- To highlight the role of C. elegans in identifying gene products and therapeutic factors for PD.
- To emphasize the advantages of C. elegans for studying neurodegeneration and neuronal dysfunction.
Main Methods:
- Utilizing Caenorhabditis elegans, a genetically tractable model organism.
- Employing traditional genetic, large-scale genomic, and pharmacological screening approaches.
- Leveraging mature bioinformatic and functional genomic data.
Main Results:
- C. elegans facilitates the identification and characterization of gene products associated with PD.
- The model system aids in understanding factors influencing neuronal dysfunction and age-associated neurodegeneration.
- Rapid screening capabilities in C. elegans accelerate disease research.
Conclusions:
- Caenorhabditis elegans is a valuable model for Parkinson's disease research.
- The nematode's genetic tractability and rapid screening make it ideal for discovering PD-related factors.
- C. elegans research is poised to significantly contribute to future PD discoveries and therapeutic development.
More Related Videos
07:20Automated Behavioral Analysis of Large C. elegans Populations Using a Wide Field-of-view Tracking Platform
Published on: November 28, 2018
05:17Assessing Gastrointestinal Motility in Caenorhabditis elegans RAC1/CED-10 Mutants as a Tool to Study Early Parkinson's Disease
Published on: November 28, 2025
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:27Diverticular Disease of the Colon
Diverticular disease involves the formation of diverticula—small sac-like outpouchings of the colonic wall—and their complications. It most commonly affects the sigmoid colon due to higher intraluminal pressure and structural vulnerability. It results from structural weakness and increased pressure in the colon, producing pseudodiverticula that may remain silent or progress to inflammation and serious complications.Structure of DiverticulaIn diverticulosis, these outpouchings are...